Showing results (311-320 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|June 19, 2024
Recently developed radiopharmaceuticals for bacterial infection imagingMaryke Kahts, Beverley Summers, Aadil Gutta, et al.
EJNMMI Radiopharmacy and Chemistry|June 4, 2024
Synthesis and evaluation of [18F]FBNAF, a STAT3-targeting probe, for PET imaging of tumor microenvironmentAnna Miyazaki, Yasukazu Kanai, Keita Wakamori, et al.
EJNMMI Radiopharmacy and Chemistry|June 6, 2024
Trans-cyclooctene-a Swiss army knife for bioorthogonal chemistry: exploring the synthesis, reactivity, and applications in biomedical breakthroughsKaruna Adhikari, Maarten Vanermen, Gustavo Da Silva, et al.
EJNMMI Radiopharmacy and Chemistry|July 15, 2024
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastomaAnthony Waked, Melissa Crabbé, Virginie Neirinckx, et al.
EJNMMI Radiopharmacy and Chemistry|May 22, 2024
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211Chiara Timperanza, Holger Jensen, Ellinor Hansson, et al.
EJNMMI Radiopharmacy and Chemistry|May 15, 2024
[68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserveMaximilian A Zierke, Christine Rangger, Kimia Samadikhah, et al.
EJNMMI Radiopharmacy and Chemistry|May 4, 2024
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscapeRaymond M Reilly, Constantine J Georgiou, Madeline K Brown, et al.
EJNMMI Radiopharmacy and Chemistry|April 27, 2024
Small animal PET imaging with the 68Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse modelYueHua Chen, ShuangShuang Song, YanQin Sun, et al.
EJNMMI Radiopharmacy and Chemistry|May 2, 2024
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applicationsAlessandra Boschi, Luca Urso, Licia Uccelli, et al.
Pageof 44